Wardlow ML - Search Results

1

192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells.

Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ. Waite JJ, et al. Among authors: wardlow ml. Neuroscience. 1995 Mar;65(2):463-76. doi: 10.1016/0306-4522(94)00479-o. Neuroscience. 1995. PMID: 7777161

2

Behavioral and biochemical consequences of combined lesions of the medial septum/diagonal band and nucleus basalis in the rat when ibotenic acid, quisqualic acid, and AMPA are used.

Waite JJ, Chen AD, Wardlow ML, Thal LJ. Waite JJ, et al. Among authors: wardlow ml. Exp Neurol. 1994 Dec;130(2):214-29. doi: 10.1006/exnr.1994.1200. Exp Neurol. 1994. PMID: 7532591

3

Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192 IgG-saporin.

Waite JJ, Wardlow ML, Chen AC, Lappi DA, Wiley RG, Thal LJ. Waite JJ, et al. Among authors: wardlow ml. Neurosci Lett. 1994 Mar 14;169(1-2):154-8. doi: 10.1016/0304-3940(94)90379-4. Neurosci Lett. 1994. PMID: 8047273

4

Deficit in selective and divided attention associated with cholinergic basal forebrain immunotoxic lesion produced by 192-saporin; motoric/sensory deficit associated with Purkinje cell immunotoxic lesion produced by OX7-saporin.

Waite JJ, Wardlow ML, Power AE. Waite JJ, et al. Among authors: wardlow ml. Neurobiol Learn Mem. 1999 May;71(3):325-52. doi: 10.1006/nlme.1998.3884. Neurobiol Learn Mem. 1999. PMID: 10196110

5

Correlation between plasma physostigmine concentrations and percentage of acetylcholinesterase inhibition over time after controlled release of physostigmine in volunteer subjects.

Knapp S, Wardlow ML, Albert K, Waters D, Thal LJ. Knapp S, et al. Among authors: wardlow ml. Drug Metab Dispos. 1991 Mar-Apr;19(2):400-4. Drug Metab Dispos. 1991. PMID: 1676644

6

Sensitive analysis of plasma physostigmine levels using dual-cell electrochemistry in the redox mode.

Knapp S, Wardlow ML, Thal LJ. Knapp S, et al. Among authors: wardlow ml. J Chromatogr. 1990 Mar 16;526(1):97-107. doi: 10.1016/s0378-4347(00)82487-1. J Chromatogr. 1990. PMID: 2341549

7

Rapid isocratic procedure for the separation of platelet-activating factor from phospholipids in human saliva by high-performance liquid chromatography.

Wardlow ML. Wardlow ML. J Chromatogr. 1985 Aug 9;342(2):380-4. doi: 10.1016/s0378-4347(00)84531-4. J Chromatogr. 1985. PMID: 4055961 No abstract available.

8

Changes in CSF neurotransmitters in infantile spasms.

Langlais PJ, Wardlow ML, Yamamoto H. Langlais PJ, et al. Among authors: wardlow ml. Pediatr Neurol. 1991 Nov-Dec;7(6):440-5. doi: 10.1016/0887-8994(91)90028-j. Pediatr Neurol. 1991. PMID: 1724602

9

Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.

Leibowitz MD, Ardecky RJ, Boehm MF, Broderick CL, Carfagna MA, Crombie DL, D'Arrigo J, Etgen GJ, Faul MM, Grese TA, Havel H, Hein NI, Heyman RA, Jolley D, Klausing K, Liu S, Mais DE, Mapes CM, Marschke KB, Michellys PY, Montrose-Rafizadeh C, Ogilvie KM, Pascual B, Rungta D, Tyhonas JS, Urcan MS, Wardlow M, Yumibe N, Reifel-Miller A. Leibowitz MD, et al. Endocrinology. 2006 Feb;147(2):1044-53. doi: 10.1210/en.2005-0690. Epub 2005 Nov 3. Endocrinology. 2006. PMID: 16269450

10

The presence of platelet-activating factor (PAF) in normal human mixed saliva.

Cox CP, Wardlow ML, Jorgensen R, Farr RS. Cox CP, et al. Among authors: wardlow ml. J Immunol. 1981 Jul;127(1):46-50. J Immunol. 1981. PMID: 7240750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters